Dr. Daniel Landi, MD
Claim this profileDuke University Medical Center
Studies Brain Tumor
Studies Glioblastoma
10 reported clinical trials
15 drugs studied
Area of expertise
1Brain Tumor
Stage IV
Stage I
Stage II
2Glioblastoma
IDH positive
Stage IV
MGMT negative
Affiliated Hospitals
Clinical Trials Daniel Landi, MD is currently running
PEP-CMV Vaccine
for Pediatric Brain Tumor
This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-grade glioma (HGG) or diffuse intrinsic pontine glioma (DIPG) as well as recurrent medulloblastoma (MB). PEP-CMV is a vaccine mixture of a peptide referred to as Component A. Component A is a synthetic long peptide (SLP) of 26 amino acid residues from human pp65. The SLPs encode multiple potential class I, class II, and antibody epitopes across several haplotypes. Component A will be administered as a stable water:oil emulsion in Montanide ISA 51. Funding Source - FDA OOPD
Recruiting1 award Phase 2
Nivolumab + DAY101
for Craniopharyngioma
The current study assesses the tolerability and efficacy of monotherapy with pan-RAF-kinase (Tovorafenib) inhibition for the treatment of children and young adults with craniopharyngioma.
Recruiting1 award Phase 210 criteria
More about Daniel Landi, MD
Clinical Trial Related7 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Daniel Landi, MD has experience with
- D2C7-IT
- 2141-V11
- Atezolizumab
- PEP-CMV
- PVSRIPO
- Avapritinib
Breakdown of trials Daniel Landi, MD has run
Brain Tumor
Glioblastoma
Malignant Glioma
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Landi, MD specialize in?
Daniel Landi, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are Stage I.
Is Daniel Landi, MD currently recruiting for clinical trials?
Yes, Daniel Landi, MD is currently recruiting for 6 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Daniel Landi, MD has studied deeply?
Yes, Daniel Landi, MD has studied treatments such as D2C7-IT, 2141-V11, Atezolizumab.
What is the best way to schedule an appointment with Daniel Landi, MD?
Apply for one of the trials that Daniel Landi, MD is conducting.
What is the office address of Daniel Landi, MD?
The office of Daniel Landi, MD is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.